Literature DB >> 28893807

Neostigmine and glycopyrronium: a potential safe alternative for patients with pseudo-obstruction without access to conventional methods of decompression.

Alfred Adiamah1, Sarah Johnson2, Adrian Ho2, James Orbell2.   

Abstract

Intestinal pseudo-obstruction mimics bowel obstruction. However, on examination, no mechanical cause is identified. This condition will often resolve when managed conservatively, yet in some cases decompression is required to avoid the serious complications of bowel ischaemia and perforation. This is performed endoscopically, and due to the invasive nature and limited access to this service, an alternative treatment option is deemed appealing. Neostigmine has good efficacy in the decompression of pseudo-obstruction but is hindered by its wide side effect profile. In this context, neostigmine requires careful monitoring, which limits its appeal. This side effect profile is minimised when neostigmine is administered in conjunction with glycopyrronium.This case demonstrates the novel use of neostigmine and glycopyrronium in decompression of the bowel in a patient with pseudo-obstruction. Furthermore, it highlights its value, particularly when conventional techniques for decompression are not accessible. © BMJ Publishing Group Ltd (unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted.

Entities:  

Keywords:  drug interactions; drug therapy related to surgery; drugs: gastrointestinal system; endoscopy; gastrointestinal system

Mesh:

Substances:

Year:  2017        PMID: 28893807      PMCID: PMC5604700          DOI: 10.1136/bcr-2017-221249

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  5 in total

1.  Neostigmine for the treatment of acute colonic pseudo-obstruction.

Authors:  R J Ponec; M D Saunders; M B Kimmey
Journal:  N Engl J Med       Date:  1999-07-15       Impact factor: 91.245

Review 2.  Systematic review: acute colonic pseudo-obstruction.

Authors:  M D Saunders; M B Kimmey
Journal:  Aliment Pharmacol Ther       Date:  2005-11-15       Impact factor: 8.171

3.  Infusion of neostigmine-glycopyrrolate for bowel evacuation in persons with spinal cord injury.

Authors:  Mark A Korsten; Alan S Rosman; Anthony Ng; Erdal Cavusoglu; Ann M Spungen; Miroslav Radulovic; Jill Wecht; William A Bauman
Journal:  Am J Gastroenterol       Date:  2005-07       Impact factor: 10.864

Review 4.  Ogilvie's syndrome-acute colonic pseudo-obstruction.

Authors:  P Pereira; F Djeudji; P Leduc; F Fanget; X Barth
Journal:  J Visc Surg       Date:  2015-03-11       Impact factor: 2.043

Review 5.  Neostigmine for acute colonic pseudo-obstruction: A meta-analysis.

Authors:  Raul Guillermo Lopez Valle; Francisco Lopez Godoy
Journal:  Ann Med Surg (Lond)       Date:  2014-06-19
  5 in total
  2 in total

Review 1.  Acute Colonic Pseudo-Obstruction.

Authors:  Thomas Arthur; Adele Burgess
Journal:  Clin Colon Rectal Surg       Date:  2022-08-12

2.  Comparison of Postoperative Gastrointestinal Motility of Sugammadex and Neostigmine in Patients Undergoing Robotic Thyroidectomy: A Retrospective Study.

Authors:  Min Jeong Lee; Duk-Hee Chun; Hee Jung Kong; Hye Jung Shin; Sunmo Yang; Na Young Kim
Journal:  J Clin Med       Date:  2022-05-22       Impact factor: 4.964

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.